Michelle Gillice focuses her practice on regulatory compliance and enforcement concerning the US Consumer Product Safety Commission (CPSC) and Drug Enforcement Administration (DEA). Following her tenure at both agencies, she now helps clients find practical solutions that reduce liability risks and protect their brands.

Ms. Gillice counsels manufacturers, importers, and online and traditional retailers of various consumer products, including household appliances, home furnishings, heating and cooling equipment, lighting products, toys and other children's products, computer equipment, lithium batteries, packaging, pharmaceutical drugs, and Internet of Things (IoT) products on compliance with the Consumer Product Safety Act (CPSA) and its implementing regulations. She regularly advises companies, including startups, on reporting obligations, avoiding unnecessary recalls, developing effective corrective action plans, penalty investigations and defending enforcement actions. Ms. Gillice works with clients to develop effective compliance policies and has extensive experience in matters involving industry voluntary standards, testing and certification, flammable fabrics, child-resistant packaging, and labeling requirements under the Federal Hazardous Substances Act. During her nine years of service at CPSC between 2002 and 2012, Ms. Gillice was the lead attorney on numerous compliance investigations, recalls, and civil penalty matters involving retailers, importers, and manufacturers. Ms. Gillice also served on a detail as legal counsel to CPSC Chairman Inez Tenenbaum, and led an interdisciplinary team on all investigations, compliance activities, and education and outreach related to infant sleep products.

In addition, Ms. Gillice counsels pharmaceutical manufacturers, wholesale distributors, hospitals, and other healthcare clients on regulatory compliance and enforcement issues involving the Controlled Substances Act (CSA) and its implementing regulations. She also advises companies on business procedures relating to DEA registration, recordkeeping, reporting, and security. Immediately prior to joining the firm in 2016, Ms. Gillice served as a senior attorney at DEA, Office of Chief Counsel, Diversion and Regulatory Litigation Section, where she represented the federal government in administrative litigation against wholesale distributors, pharmacies, and practitioners for alleged violations of the CSA.

Perspectives

Addressing the Opioid Crisis: What Life Sciences and Healthcare Companies Need to Know About the SUPPORT for Patients and Communities Act
Advisory
CPSC Notification Requirements, Recalls and Recent Enforcement Actions: Desk Reference for Section 15 of the Consumer Product Safety Act
Desk Reference
How CPSC Late Reporting Penalty Trends Are Evolving
Appellate Law360, Consumer Protection Law360, Illinois Law360, Product Liability Law360, Retail & E-Commerce Law360, Texas Law360, Trials Law360
President Trump to Nominate Dana Baiocco to be CPSC Commissioner, Signaling Shift in Control
Seller Beware: Consumer Protection Insights for Industry
CPSC Reduces Testing Requirements for Phthalates in Children's Toys and Childcare Articles
Seller Beware: Consumer Protection Insights for Industry
More

Recognition

The Legal 500 US
Product Liability and Mass Tort Defense: Pharmaceuticals and Medical Devices (2017)
Product Liability, Mass Tort and Class Action: Consumer Products (including tobacco) (2017)

Credentials

Education
  • JD, American University Washington College of Law, 1997
  • BS, Syracuse University, 1992, cum laude
Admissions
  • District of Columbia
Overview

Email Disclaimer